Chembio Diagnostics
ProciseDx Gets US Marketing Clearance for Infliximab, Adalimumab POC Monitoring Tests
The firm plans this year to launch in the US its tests used to measure drug levels in inflammatory bowel disease patients and guide treatment.
The firm plans this year to launch in the US its tests used to measure drug levels in inflammatory bowel disease patients and guide treatment.